Sinobiom Overview

  • Year Founded
  • 2007

Year Founded

  • Status
  • Private

  • Employees
  • 135

Employees

  • Latest Deal Type
  • Series B

  • Latest Deal Amount
  • $30.9M

  • Investors
  • 2

Sinobiom General Information

Description

Developer and producer of biomaterials based on controllable polymer polymerization technology and multi-factor polymer physical modification technology. The company is mainly engaged in the research and production of medical-grade biodegradable polymer materials for passive implanted medical devices, such as orthopedics, sports medicine, 3D printing, plastic surgery, neurosurgery, and oral cavity.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • No. 666A, Chaoqun Street
  • High-tech Industrial Development Zone
  • Changchun, Jilin
  • China
+86 0431
Primary Industry
Medical Supplies
Other Industries
Surgical Devices
Vertical(s)
Corporate Office
  • No. 666A, Chaoqun Street
  • High-tech Industrial Development Zone
  • Changchun, Jilin
  • China
+86 0431

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Sinobiom Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
2. Later Stage VC (Series B) 16-Jul-2021 $30.9M Completed Generating Revenue
1. Later Stage VC (Series A) 23-Dec-2019 Completed Generating Revenue
To view Sinobiom’s complete valuation and funding history, request access »

Sinobiom Patents

Sinobiom Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
WO-2026086180-A1 Use of poly (l-lactide) or copolymer comprising l-lactic acid repeating units in prevention or treatment of obesity-related diseases Pending 24-Oct-2024
WO-2026051079-A1 Hair growth Pending 09-Sep-2024
AU-2024296915-A1 Polylactic acid and use of copolymer thereof in preparation of drug for promoting nerve growth and repair Pending 12-Jul-2023
EP-4744670-A1 Polylactic acid and use of copolymer thereof in preparation of drug for promoting nerve growth and repair Pending 12-Jul-2023
WO-2025011563-A1 Polylactic acid and use of copolymer thereof in preparation of drug for promoting nerve growth and repair Inactive 12-Jul-2023 A61K31/765
To view Sinobiom’s complete patent history, request access »

Sinobiom Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Sinobiom Investors (2)

Investor Name Investor Type Holding Investor Since Participating Rounds
Sino-Ocean Capital Asset Manager Minority
Changchun Financial Holding Group Government Minority
To view Sinobiom’s complete investors history, request access »

Sinobiom FAQs

  • When was Sinobiom founded?

    Sinobiom was founded in 2007.

  • Where is Sinobiom headquartered?

    Sinobiom is headquartered in Changchun, China.

  • What is the size of Sinobiom?

    Sinobiom has 135 total employees.

  • What industry is Sinobiom in?

    Sinobiom’s primary industry is Medical Supplies.

  • Is Sinobiom a private or public company?

    Sinobiom is a Private company.

  • What is Sinobiom’s current revenue?

    The current revenue for Sinobiom is .

  • How much funding has Sinobiom raised over time?

    Sinobiom has raised $30.9M.

  • Who are Sinobiom’s investors?

    Sino-Ocean Capital and Changchun Financial Holding Group have invested in Sinobiom.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process